PWA
PFE icon

Pitcairn Wealth Advisors’s Pfizer PFE Stock Holding History

Pitcairn Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
14,921
-4,665
-24% -$122K 0.04% 221
2026
Q1 		$488K Buy
19,586
+935
+5% +$24.9K 0.04% 184
2025
Q4 		$464K Buy
+18,651
New +$470K 0.04% 190

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pitcairn Wealth Advisors's PFE Position: Q2 2026 in Review

Pitcairn Wealth Advisors reduced its Pfizer (PFE) stake by 24% in Q2 2026, selling an estimated $122K and leaving 14,921 shares worth $359K. The position accounts for 0.04% of the portfolio, ranked #221.

Pitcairn Wealth Advisors first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $488K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pitcairn Wealth Advisors held 14,921 shares of Pfizer worth $359K as of Q2 2026.
  • Pitcairn Wealth Advisors sold 4,665 Pfizer shares in Q2 2026, an estimated $122K.
  • Pfizer made up 0.04% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #221 holding.
  • Pitcairn Wealth Advisors first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Pitcairn Wealth Advisors's Pfizer position peaked at $488K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.